Cargando…
Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals
OBJECTIVE: Although the adaptive immune response to SARS‐CoV‐2 has been characterised in the acute and early convalescent phase of the disease, few studies explore whether natural infection elicits long‐lasting immunological memory in recovered individuals. In this work, we aimed to assess the maint...
Autores principales: | Mazzoni, Alessio, Maggi, Laura, Capone, Manuela, Vanni, Anna, Spinicci, Michele, Salvati, Lorenzo, Tekle Kiros, Seble, Semeraro, Roberto, Pengue, Luca, Colao, Maria Grazia, Magi, Alberto, Rossolini, Gian Maria, Liotta, Francesco, Cosmi, Lorenzo, Bartoloni, Alessandro, Annunziato, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101693/ https://www.ncbi.nlm.nih.gov/pubmed/33976879 http://dx.doi.org/10.1002/cti2.1281 |
Ejemplares similares
-
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4(+) T lymphocytes with implications for booster strategies
por: Mazzoni, Alessio, et al.
Publicado: (2022) -
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH)
por: Lamacchia, Giulia, et al.
Publicado: (2022) -
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization
por: Lamacchia, Giulia, et al.
Publicado: (2022) -
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
por: Mazzoni, Alessio, et al.
Publicado: (2022) -
Impaired response to first SARS‐CoV‐2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib
por: Guglielmelli, Paola, et al.
Publicado: (2021)